RAD-140 Sarm Liquid Portugal
Investigational Selective Androgen Receptor Modulator RAD-140 liquid, Testolone, was developed in partnership with the Food and Drug Administration (FDA). By acting on the male sex hormone testosterone, RAD-140 may diminish or prevent the onset of benign prostatic hyperplasia (BPH) in males.
RAD-140 Liquid prevents the male sex hormone testosterone from attaching to its receptor sites in the prostate by binding it. RAD-140 sarm binds androgen receptors in muscle and bone tissue selectively, resulting in a rapid increase in muscle and bone density.
In addition to promoting the rapid development of lean muscle mass and the burning of excess body fat, the increased density of the bones helps to strengthen them.
RAD-140 has been used in the treatment breast cancer and diseases that affect brain health such as Alzheimer’s disease.
Without having the side effects of anabolic steroids on the reproductive organs. Rad-140 Liquid allow weight and muscle gain whilst not increasing the growth of the prostate gland.
Benefits of RAD-140 Liquid
Enhanced Muscle Mass – The majority of serious diseases, such as AIDS and cancer, result in muscle atrophy and weakness. The muscle-building function of RAD 140 can assist in reversing this condition and enhancing muscle gain. Studies have found that this substance can improve the weight of men with prostate cancer and because of its selectivity, it does not stimulate the growth of the prostate like testosterone does.
Reduction of Fat – Those who supplement with Testosterone frequently claim significant fat loss. Directly enhancing fat oxidation, RAD 140 also indirectly lowers fat tissue by increasing muscle mass. Additionally, increased muscular mass increases the metabolism and promotes fat reduction.
Breast Cancer Prevention – RAD140 has demonstrated clinically encouraging results in the treatment of breast cancer. It lowers breast cancer cell proliferation by inhibiting estrogen’s effects on tissues. RAD140 inhibits the production of ESR1, a protein implicated in the progression of cancer.
Treatment for Neurodegenerative Diseases – RAD140 protects rat brains from damage caused by A (amyloid-beta) proteins, which are the primary proteins linked to the development of AD (Alzheimer’s disease). RAD140 reduces A and promotes brain cell development and synaptic plasticity, which are crucial for learning and memory.
DISCLAIMER: We do not supply Peptides or Sarms to any individual under the age of 18. You must be a licensed and qualified healthcare practitioner. All products listed on this website (https://pharmagrade.store) and provided through Pharma Grade are intended ONLY FOR medical research purposes. Pharma Grade Portugal does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption) nor are the products intended as a drug, stimulant or for use in any food products.